EUVIMEDEUVIMED entdecken
Fallbericht

A Multicentric Castleman Disease Associated with Mixed Warm and Cold Antibody-Mediated AHA Responsive to Siltuximab

Federica Plano, Salvatrice Mancuso, Giulia Maria Camarda, Maria Giulia Butera, Giuseppe Sucato, Giuseppe Alecci, Ada Maria Florena, Salvatore Perrone, Sergio Mario Siragusa

Chemotherapy · 2024

DOI: 10.1159/000533235 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Chemotherapy, 2024. Verfasst von Federica Plano und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties (PROMISE), University of Palermo, Palermo, Italy. Hauptthemen laut MEDLINE: Castleman Disease. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 16 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Castleman disease is non-clonal lymphoproliferative disorders defined by hypertrophy of lymph nodes. The multicentric form (MCD), in which multiple lymph node stations are involved, is not associated with HHV8 infection, but considered idiopathic, although IL-6 appears to play a central role in its pathogenesis. Here, we report the case of a patient who presented with mixed autoimmune hemolytic anemia (AIHA) and adenopathy that was very challenging to diagnose due to very low values of hemoglobin and refractoriness of obtaining any improvement of AIHA with standard first and second lines of therapy (steroids, rituximab, immunoglobulin, erythropoietin, and cyclosporine). When we safely proceeded to lymph node biopsy, a diagnosis of MCD was established. This permitted the treatment with siltuximab, an anti-IL-6 monoclonal antibody. After only 1 week, hemoglobin raised and he was discharged. After 1 year, he was still in remission. This case underlines the challenges in diagnosis of MCD, and the first case of response to siltuximab after the failure of rituximab to relieve mixed AIHA.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Castleman DiseaseMaleHumansRituximabAntibodies, MonoclonalHemoglobins

Stichwörter der Autor:innen

Autoimmune hemolytic anemiaCastleman diseaseRituximabSiltuximab

Substanzen

siltuximabRituximabAntibodies, MonoclonalHemoglobins

Autor:innen und Institutionen

  • Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties (PROMISE), University of Palermo, Palermo, Italy.
  • Hematology Division, University Hospital Policlinico "Paolo Giaccone,", Palermo, Italy.

Zitieren

APA

Plano, F., Mancuso, S., Camarda, G. M., Butera, M. G., Sucato, G., Alecci, G., Florena, A. M., Perrone, S., & Siragusa, S. M. (2024). A Multicentric Castleman Disease Associated with Mixed Warm and Cold Antibody-Mediated AHA Responsive to Siltuximab. Chemotherapy. https://doi.org/10.1159/000533235

Vancouver

Plano F, Mancuso S, Camarda GM, Butera MG, Sucato G, Alecci G, et al. A Multicentric Castleman Disease Associated with Mixed Warm and Cold Antibody-Mediated AHA Responsive to Siltuximab. Chemotherapy. 2024. doi:10.1159/000533235

BibTeX
@article{Plano2024,
  author = {Plano, Federica and Mancuso, Salvatrice and Camarda, Giulia Maria and Butera, Maria Giulia and Sucato, Giuseppe and Alecci, Giuseppe and Florena, Ada Maria and Perrone, Salvatore and Siragusa, Sergio Mario},
  title = {A Multicentric Castleman Disease Associated with Mixed Warm and Cold Antibody-Mediated AHA Responsive to Siltuximab},
  journal = {Chemotherapy},
  year = {2024},
  doi = {10.1159/000533235}
}
Kostenlos starten →